ANGEN.E — Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret A Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapFalling Star

Market Cap
TRY3.08bn
Enterprise Value
TRY2.73bn
Revenue
TRY268.82m

Annual balance sheet for Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret A, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	Interim Report	Interim Report	Interim Report	ARS	ARS
Standards:	—	—	—	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	0.932	2.36	135	514	425
Net Total Accounts Receivable
Net Total Receivables	7.43	10.7	115	105	83.1
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	10.1	18.8	316	708	625
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.87	7.08	64.5	129	187
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	19.8	34.2	396	860	857
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	6.45	9.82	54.9	28	18.4
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	11	18	85.9	93	40.5
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	8.74	16.2	310	767	816
Total Liabilities & Shareholders' Equity	19.8	34.2	396	860	857
Total Common Shares Outstanding